TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
BYSI

BeyondSpring Inc

Healthcare · Biotechnology

0.8059$ +25.2% vs. previous close Closing price · As of: Nov 2, 2026

Ownership

Ownership Structure

Who owns BeyondSpring Inc (BYSI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 77.7% of the shares are freely tradable; institutional investors hold 14.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 14.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 14.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 77.7%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 41Mio.

Largest Shareholders

Institutions

Institutions BYSI
Name Stake (%) Shares Change (%) Date
Decheng Capital LLC 9.24 3,800,702 +0.0 06/30/2026
BlackRock Inc 1.64 672,915 +3.6 06/30/2026
Vanguard Capital Management, LLC 1.52 626,457 +3.0 06/30/2026
Geode Capital Management, LLC 0.89 367,740 -2.0 06/30/2026
State Street Corp 0.56 231,120 +0.0 06/30/2026
Vanguard Fiduciary Trust Co 0.44 181,196 +0.7 06/30/2026

Funds

Funds BYSI
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 0.86 352,094 +0.0 09/30/2026
Fidelity Extended Market Index 0.38 157,215 -0.5 08/31/2026
iShares Micro-Cap ETF 0.25 101,440 -0.7 09/30/2026
Fidelity Total Market Index 0.16 66,108 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?